Antithrombotic therapy in peripheral artery disease--antiplatelet therapy, anticoagulants, both or none.
Tangelder
Marco J D
MJ
Department of Vascular Surgery G.04.129, University Medical Center Utrecht, Utrecht, The Netherlands. m.tangelder@umcutrecht.nl
van Hattum
Eline S
ES
D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control*; D019317:Evidence-Based Medicine; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D018579:Patient Selection; D058729:Peripheral Arterial Disease / Q000150:complications / Q000188:drug therapy*; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D018570:Risk Assessment; D012307:Risk Factors; D016896:Treatment Outcome
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors